Eton Pharmaceuticals (ETON) Other Non-Current Assets (2017 - 2026)

Eton Pharmaceuticals has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $64000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Assets rose 433.33% year-over-year to $64000.0; the TTM figure through Jun 2026 stood at $64000.0 (up 433.33% YoY), while the FY2025 annual figure was $19000.0, up 58.33% from the prior year.
• Other Non-Current Assets came in at $64000.0 for Q2 2026 at Eton Pharmaceuticals, up from $19000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $64000.0 in Q2 2026 to a low of $12000.0 in Q1 2022.
• Average Other Non-Current Assets over 5 years is $15882.4, with a median of $12000.0 recorded in 2022.
• Year-over-year, Other Non-Current Assets plunged 66.67% in 2022 and jumped 433.33% in 2026.
• Over 5 years, Other Non-Current Assets stood at $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then jumped by 58.33% to $19000.0 in 2025, then surged by 236.84% to $64000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $64000.0 in Q2 2026, $19000.0 in Q4 2025, and $19000.0 in Q3 2025.